[Inhibition of progression of decreasing bone mass and manifest osteoporosis].
Ringe
J D
JD
Medizinische Klinik IV, Städtisches Krankenhaus Leverkusen.
D000368:Aged; D015519:Bone Density / Q000187:drug effects / Q000502:physiology; D001842:Bone and Bones / Q000187:drug effects / Q000503:physiopathology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology
Progressionshemmung bei Verminderung der Knochenmasse und manifester Osteoporose.